Marianna Wharry

June 17, 2024 | The Recorder

Scalr brought claims of direct infringement of the plaintiff's rights under the U.S. Copyright Act, contributory copyright infringement, inducement of copyright infringement, unfair competition under California Business and Professional Code Section 17200 as to UnitedLex's use and sales in California.

By Marianna Wharry

3 minute read

June 14, 2024 | Law.com

"We disagree the court lacked appellate jurisdiction. As we explained in our brief, appellate courts consider district court decisions that go to the merits of the case, which the Wyoming decision certainly did," May Mailman, who represented the sorority sisters, told Law.com in a statement. "Women deserve the camaraderie and safety of sororities, but unfortunately, it also appears they first need courts brave enough to say so."

By Marianna Wharry

4 minute read

June 11, 2024 | Law.com

"Fortune 500 companies should know better than to exclude hardworking older Americans from jobs by targeting 'recent college graduates' in hiring posts," Adam Klein, managing partner at Outten & Golden, said in a statement.

By Marianna Wharry

4 minute read

June 11, 2024 | New York Law Journal

"Google operates a shopping marketplace that is essentially a thieves' den. It is rife with pirates, while excluding similar ads from legitimate sellers," Matthew Oppenheim, managing partner of Oppenheim & Zebrak, said in a statement. "Google has been told over and over again about the pirates, but puts its own profits ahead of the law."

By Marianna Wharry

3 minute read

June 10, 2024 | Law.com

"We're grateful that these three nominees are ready and eager to continue their service to Massachusetts," Lt. Gov. Kim Driscoll said in a statement. "I am excited to work with the Governor's Council as they consider these terrific nominees."

By Marianna Wharry

3 minute read

June 04, 2024 | Law.com

"We will continue to pursue legal action against those who provide potentially unsafe and ineffective compounded 'semaglutide' products and knowingly deceive patients who are seeking treatment, thereby eroding public trust in the safety of FDA-approved medicines," said Doug Langa, executive vice president, North America operations and president of Novo Nordisk.

By Marianna Wharry

4 minute read

June 03, 2024 | Delaware Law Weekly

"I remain immensely grateful to Vice Chancellor (J. Travis) Laster, Blake Rohrbacher, and the subcommittee members for their commitment to this project," Chancellor Kathaleen St. Jude McCormick said in a statement. "Each subcommittee member's participation was essential to this project and our system is better thanks to their efforts."

By Marianna Wharry

2 minute read

May 31, 2024 | The Recorder

"It's a huge problem kids are suffering from with huge increases in hospitalizations and treatments, it is crushing and ruining kids' lives," Sarah R. London, partner at Lieff Cabraser Heimann & Bernstein, told Law.com. "[Providing] clear, unambiguous information for anyone to understand the risks of these products is essential. People are trying to get truth information so they can decide what to do when it comes to these products."

By Marianna Wharry

4 minute read

May 28, 2024 | Delaware Law Weekly

Pfizer recently filed seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication, Nurtec, which is used to prevent and treat migraines.

By Marianna Wharry

2 minute read

May 28, 2024 | Law.com

Associate Justice Gabrielle Wolohojian wrote that while the transfer could constitute an adverse employment action, with such issues as a lifestyle change and family life balance, there was no factual showing to support the union's claim.

By Marianna Wharry

3 minute read